Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMGEUR

(AMGEUR)

Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
09/17/20247:03AMBusiness WireVertical Aerospace Announces First Half-Year 2024 Financial ResultsNYSE:EVTLVertical Aerospace Ltd
09/17/20247:03AMBusiness WireCamunda Orchestrates SAP Environments
09/17/20247:03AMBusiness WireMatco Tools, A Vontier Company, Named a 2024 Motor Top 20 Award WinnerNYSE:VNTVontier Corporation
09/17/20247:03AMPR Newswire (US)Caring Senior Service founder to speak about AI at National Aging in Place Council Conference
09/17/20247:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:STOHFEquinor ASA (PK)
09/17/20247:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
09/17/20247:02AMBusiness WireMagnolia Federal Credit Union Chooses Pulsate for Data-Driven Mobile-First Engagement
09/17/20247:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:MTTCFSteakholder Foods Ltd (PK)
09/17/20247:01AMBusiness WireKinaxis Provides Business UpdateTSX:KXSKinaxis Inc
09/17/20247:01AMBusiness WireBrightside Health Expands to Serve Teens
09/17/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVGNEvogene Ltd
09/17/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:MNSOMINISO Group Holding Limited
09/17/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CTGOContango Ore Inc
09/17/20247:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
09/17/20247:00AMGlobeNewswire Inc.Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsNASDAQ:OMGAOmega Therapeutics Inc
09/17/20247:00AMBusiness WireKalibrate announces acquisition of IMST Corp.
09/17/20247:00AMGlobeNewswire Inc.Century Announces Resumption of Normal Shipping Operations at Jamalco RefineryNASDAQ:CENXCentury Aluminum Co
09/17/20247:00AMBusiness WireLaser Photonics To Deliver DefenseTech Laser Cleaning Tool to Pearl Harbor Naval Shipyard & IMTFNASDAQ:LASELaser Photonics Corporation
09/17/20247:00AMGlobeNewswire Inc.Industry leaders to speak at Wood Mackenzie’s Carbon Capture, Utilization and Storage Conference 2024
09/17/20247:00AMGlobeNewswire Inc.ADMA Biologics Set to Join S&P SmallCap 600 IndexNASDAQ:ADMAAdma Biologics Inc
09/17/20247:00AMGlobeNewswire Inc.Vigil Neuroscience Announces FDA Has Removed Partial Clinical Hold on VG-3927NASDAQ:VIGLVigil Neuroscience Inc
09/17/20247:00AMGlobeNewswire Inc.DAVIDsTEA Reports Financial Results for Second Quarter of Fiscal 2024TSXV:DTEADavidsTea Inc
09/17/20247:00AMBusiness WireUniversity of Toronto Press Acquires Linguistics List from Equinox Publishing
09/17/20247:00AMGlobeNewswire Inc.Xtract One Technologies Launches New Gateway: Weapons Detection for Customers with Laptops and Other Large Items0PL
09/17/20247:00AMBusiness WireSun Moon Rising Launches World’s First Astrology-Inspired Wine Brand
09/17/20247:00AMBusiness WireF5 Launches NGINX One, Simplifies App Security and Delivery for Dev, Ops, and Platform TeamsNASDAQ:FFIVF5 Inc
09/17/20247:00AMBusiness WireKobo Resources Resumes Diamond Drilling at its 100%-Owned Kossou Gold Project with 10,000-Metre Program Focused on High-Potential Gold TargetsTSXV:KRIKobo Resources Inc
09/17/20247:00AMBusiness WireNorth Hills School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All StudentsNYSE:NRDYNerdy Inc
09/17/20247:00AMBusiness WireSES AI Collaborates with NVIDIA, Crusoe, and Supermicro on AI for Science Initiative to Accelerate Material Discovery in Electric TransportationNYSE:SESSES AI Corporation
09/17/20247:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic DermatitisNASDAQ:ACRSAclaris Therapeutics Inc